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Abstract
Introduction: Metabolic syndrome (MetS) is a conste-
llation of metabolic alterations related to abdominal obe-
sity, inflammation and insulin resistance, which increase 
cardiovascular disease and mortality. The aims of the 
present study were to identify the prevalence of comor-
bidities and altered parameters in obese adolescents with 
and without MetS, and determine cut-off points of waist 
circumference to predict MetS.
Methods: 195 obese adolescents were recruited and di-
vided according to MetS diagnosis based on IDF criteria. 
Blood analyses of glucose, lipids, liver enzymes, adipo-
nectin and leptin were measured. Insulin resistance was 
assessed by HOMA-IR, QUICKI and HOMA-AD. Visce-
ral, subcutaneous and hepatic fat were ultrasonography 
obtained. Body composition was estimated by BOD POD 
system. 
Results: We observed a prevalence of 25% of MetS 
(n=50). The MetS group presented significantly higher 
body mass, BMI, body fat (kg), free-fat mass (kg), waist 
circumference, visceral fat, glucose, insulin, insulin resis-
tance, total-cholesterol, LDL-c, VLDL-c, triglycerides, li-
ver enzymes, blood pressure and non-alcoholic fatty liver 
disease (NAFLD). Significant lower QUICKI and adipo-
nectin were noted in MetS group. MetS girls presented 
significantly higher leptin/adiponectin ratio compared to 
Non-MetS girls. Cut-off points of 111.5 cm for boys and 
104.6 cm for girls of waist circumference were suggested 
to predict metabolic syndrome. Moreover, waist circum-
ference was positively correlated with visceral fat and the 
number of metabolic syndrome parameters.
LOS VALORES DE CORTE DE 
CIRCUNFERENCIA DE CINTURA PARA 
PREDECIR EL SÍNDROME METABÓLICO EN 
ADOLESCENTES OBESOS
Resumen
Introducción: El síndrome metabólico es una conste-
lación de alteraciones metabólicas relacionadas con la 
obesidad abdominal, la inflamación y la resistencia a la 
insulina, lo que aumenta las enfermedades cardiovascu-
lares y la mortalidad. Los objetivos del presente estudio 
fueron determinar la prevalencia de comorbilidades y 
parámetros alterados en adolescentes obesos con y sin 
SM, y determinar los puntos de corte de la circunferencia 
de cintura para predecir SM.
Métodos: 195 adolescentes obesos y se los dividió se-
gún síndrome metabólico diagnóstico basado en criterios 
de la IDF. Los análisis de sangre se midieron de gluco-
sa, lípidos, enzimas hepáticas, la adiponectina y leptina. 
Resistencia a la insulina se evaluó mediante HOMA-IR, 
QUICKI y HOMA-AD. Se obtuvieron ecografía visceral, 
subcutánea y grasa hepática. La composición corporal se 
calcula por el sistema BOD POD.
Resultados: Se observó una prevalencia del 25% de 
síndrome metabólico Mets (n = 50). El grupo grupo con 
síndrome metabólico presentó mayor masa corporal, 
índice de masa corporal, grasa corporal (kg), sin gra-
sa masa significativa (kg), circunferencia de la cintura, 
la grasa visceral, la glucosa, la insulina, resistencia a la 
insulina, colesterol total, LDL-c, VLDL-c, triglicéridos, 
enzimas hepáticas, enfermedad no alcohólica del híga-
do graso (EHNA) y la presión arterial. Se observaron 
QUICKI significativamente menor y la adiponectina en 
el grupo con síndrome metabólico. El grupo con síndro-
me metabólico presentaron significativa proporción de 
leptina / adiponectina mayor en comparación con los que 
no tienen síndrome metabólico. Puntos de corte de 111,5 
cm para los niños y 104,6 cm para las niñas de la circun-
ferencia de cintura se sugirieron para predecir el síndro-
me metabólico. Además, la circunferencia de la cintura 
fue positivamente correlacionada con la grasa visceral y 
el número de parámetros del síndrome metabólico.
Correspondence: Deborah CL Masquio and Ana R Dâmaso. 
Rua Botucatu, 862, 2º andar,  
Ed. Ciências Biomédicas-Fisiologia da Nutrição.  
Vila Clementino – São Paulo/SP – Brasil.  
Postal code: 04023-060. 
E-mail:  deborahmasquio@yahoo.com.br / ana.damaso@unifesp.br 
Recibido: 28-XI-2014. 
Aceptado: 20-XII-2014.
012_8442 Los valores de corte de circunferencia.indd   1540 24/03/15   21:34
1541Nutr Hosp. 2015;31(4):1540-1550Cut-off  values of waist circumference 
to predict metabolic syndrome in obese 
adolescents
Abbreviations
A/L ratio: Adiponectin/leptin ratio 
ALT: Alanine Aminotransferase 
AST: Aspartate Aminotransferase
BMI: Body Mass Index 
CDC: Center for Disease Control
DBP: Diastolic Blood Pressure
GGT: Gama Glutamil Transferase
HDL-c:  High Density Lipoprotein-cholesterol
HOMA-AD: Homeostasis Model Assessment -Adi-
ponectin
HOMA-IR: Homeostasis Model Assessment - Insu-
lin Resistance 
IDF: International Diabetes Federation
IL-6: Interleukin 6
L/A ratio: Leptin/adiponectin ratio
LDL-c: Low Density Lipoprotein-cholesterol
MBP: Mean Blood Pressure
MetS: Metabolic Syndrome
NAFLD: Non Alcoholic Fatty Liver Disease
PAI-1: Plasminogen Activator Inhibitor 1
QUICKI: Quantitative Insulin Sensitivity Check In-
dex
SBP: Systolic Blood Pressure
TC: Total cholesterol
TG: Triglycerides
TNF-α: Tumor Necrosis Fator α
VLDL-c: Very Low Density Lipoprotein -cholesterol
Introduction
The prevalence of childhood obesity is increasing, 
and about 40 million preschool children worldwide 
were overweight or obese in 2010, which represents an 
increase of 60% in the last two decades1.  The obesity 
in childhood is associated with risk factors related to 
cardiovascular disease later in life.  In a population-ba-
sed study, obesity during childhood was the strongest 
risk factor for metabolic syndrome (MetS)2.
MetS is defined by a combination of alterations, 
including hyperlipidaemia, insulin resistance, hyper-
glycemia, hypertension and abdominal obesity, which 
consist in a constellation of an interconnected physio-
logical, biochemical, clinical and metabolic factors. In 
Conclusion: MetS group presented significantly hi-
gher metabolic alterations and inflammation compared 
to Non-MetS group. Waist circumference is considered 
an anthropometric measure predictor of metabolic sy-
ndrome in obese adolescents, being useful in clinical 
practice.
(Nutr Hosp. 2015;31:1540-1550)
DOI:10.3305/nh.2015.31.4.8442
Key words: Metabolic syndrome. Cut off point. Waist 
circumference. Non-alcoholic fatty liver disease and inflam-
mation.
Conclusión: El grupo con síndrome metabólico pre-
sentan alteraciones metabólicas significativas superiores 
e inflamación en comparación con el grupo sin síndrome 
metabólico. La circunferencia de cintura se considera un 
predictor medida antropométrica del síndrome metabóli-
co en adolescentes obesos, siendo útil en la práctica clínica.
(Nutr Hosp. 2015;31:1540-1550)
DOI:10.3305/nh.2015.31.4.8442
Palabras clave: Síndrome metabólico. Cortaron punto. 
Circunferencia de la cintura. La enfermedad de hígado gra-
so no alcohólico y la inflamación.
this regard, MetS confers a 5-fold increase in the risk 
of type 2 diabetes mellitus and 2-fold the risk of de-
veloping cardiovascular disease over the next 5 to 10 
years3. The presence of metabolic alterations in chil-
dren and adolescents with obesity is remarkable, being 
necessary to be investigated and treated4.
The abdominal fat is considered the key determinant 
of metabolic risk, since the pro-inflammatory adipo-
kines secreted by visceral fat are related to increased 
blood pressure, dyslipidemia and insulin resistance5-6. 
In obese adolescents, high levels of pro-inflammatory 
adipokines and reduced levels of anti-inflammatory 
adipokines, such as, leptin and adiponectin respecti-
vely, are associated with metabolic disorders, such as, 
insulin resistance, high levels of glucose, dyslipidemia 
and elevated carotid intima media thickness7-9. In this 
way, abdominal fat accumulation can mediate the as-
sociation between obesity and cardiovascular risks10.
Atherogenic risk factors, fibrinolysis, oxidative 
stress and hypoadiponectinemia often cluster with 
MetS and cardiovascular risks5. Furthermore, hyper-
leptinemia has been related to cardiovascular risks 
and atherosclerosis process. Hyperleptinemic obese 
adolescents were unable to increase adiponectin con-
centration after weight loss, which suggests the role of 
hyperleptinemia in the impairment of the attenuation 
of inflammation and thus leading to a decrease in vas-
cular protection11. On the other hand, hypoadiponecti-
nemia is related to increase cardiovascular risks, such 
as metabolic syndrome, type 2 diabetes and atheros-
clerosis in obese patients7-9. 
Recently, non-alcoholic fatty liver disease (NA-
FLD) is considered an emerging public health concern 
that parallels rise in obesity and MetS. The relations-
hip between NAFLD and the features of the MetS have 
been extensively reported, and waist circumference 
can also predict it12.
Although children and adolescents with MetS pre-
sent increased risk of cardiometabolic outcomes du-
ring adulthood, they are not destined for a lifetime 
of increased risk if they treat the MetS status early in 
life13. Reports from the Young Finns Study cohort de-
monstrated that after 6 year, the subjects that recovery 
MetS had beneficial impact on preclinical atheroscle-
rosis estimated by carotid intima media thickness when 
compared to those who had persistent MetS diagnoses, 
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indicating the importance of diagnoses and treatment 
of MetS for preventing atherosclerosis process and fu-
ture cardiac events14.
Although defined as an indirect method, waist circum-
ference is considered an important measure correlated 
with visceral fat accumulation, including in obese ado-
lescents15. Data from the Bogolusa Heart Study showed a 
high cardiometabolic risk among normal and overweight 
children with abdominal obesity compared to overweight 
children without excessive abdominal fat accumulation16. 
In this way, waist circumference need to be conside-
red in clinical practice in order to estimate the risks of 
abdominal fat accumulation and as a predictor of cardio-
metabolic risks, such as, MetS. The data mentioned abo-
ve reinforce the importance of the definition of referen-
ce values of waist circumference for the prognostic of 
MetS to improve obesity comorbidities. Therefore, the 
first aim of the present study was to identify the preva-
lence of comorbidities and altered parameters in obese 
adolescents with and without MetS. The second objecti-
ve was to determine cut-off points of waist circumferen-
ce to predict MetS in obese adolescents of both genders. 
Methods
Subjects
This cross-sectional study involved 195 obese 
adolescents aged from 15 to 19 years. All partici-
pants met  the inclusion criteria of post-pubertal Tan-
ner  Stage ≥ V and a body mass index (BMI) >95th 
percentile of CDC. Endocrinologist completed a cli-
nical interview to determine inclusion and exclusion 
criteria. Exclusion criteria included identified genetic, 
previous drug utilization, chronic alcohol consump-
tion (≥20 g/d), presence of viral hepatic diseases, and 
other causes of liver steatosis.
This study was conducted according to the principles 
laid down in the Declaration of Helsinki, was approved 
by Institutional Ethical Committee (72538) of Univer-
sidade Federal de São Paulo, and was registered with 
ClinicalTrials.gov (NCT01358773). Informed consent 
was obtained from all participants and/or their parents. 
Anthropometric measurements and body composition
Volunteers were weighed while wearing light clo-
thing and barefoot on a Filizola scale to the nearest 0.1 
kg. Height was assessed using a stadiometer with a pre-
cision of 0.1 cm (Sanny, São Bernardo do Campo, SP, 
Brazil; model ES 2030). BMI was calculated as body 
weight divided by height squared (wt/ht2). For the deter-
mination of waist circumference, subjects were placed in 
a standing position with the abdomen and arms relaxed 
alongside the body, and a flexible measuring tape (1mm 
accuracy) was held horizontally at the midpoint between 
the bottom edge of the last rib and the iliac crest. Body 
composition was estimated by Plethysmography Air 
Displacement in the BOD POD system (version 1.69, 
Life Measurement Instruments, Concord, CA, USA).
Visceral and subcutaneous adiposity, and Hepatic 
Steatosis
Visceral and subcutaneous fat were estimated by abdo-
minal ultrasonography by one physician blinded to sub-
ject assignment groups. Subcutaneous fat was defined as 
the distance between the skin and superficial plane of the 
rectus abdominal muscle. Visceral fat was defined as the 
distance between the deep plane of the same muscle and 
the anterior wall of the aorta17. Steatosis evaluation was 
performed based on criteria reported earlier8.
Blood Pressure
Systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) were measured on the right arm using 
a mercury-gravity manometer with appropriate cuff 
size. Mean blood pressure (MBP) was calculated as 
DBP+[(SBP−DBP)/3].
Serum analysis
Blood samples were collected after a 12-hour overni-
ght fast. Concentrations of glucose, insulin, triglycerides 
(TG), total cholesterol (TC), high density lipoprotein-cho-
lesterol (HDL-c), low density lipoprotein-choleste-
rol (LDL-c), very low density lipoprotein-cholesterol 
(VLDL-c) and hepatic transaminases [alanine amino-
transferase (ALT), aspartate aminotransferase (AST) 
and gama glutamil transferase (GGT)] were determined 
by enzymatic colorimetric methods (CELM, Barueri, 
Brasil). The ratios of lipoproteins levels (TC/HDL-c, 
LDL-c/HDL-c, and TG/HDL-c) were also calculated.
Leptin and adiponectin were measured by enzy-
me-linked immunosorbent assay (ELISA) kit from 
R&D Systems (Minneapolis, MN, USA). For this 
study, leptin data was analyzed according to referen-
ce values18. The pro-inflammatory leptin/ adiponectin 
ratio (L/A ratio) and anti-inflammatory adiponectin/
leptin ratio (A/L ratio) biomarkers were calculated. 
Insulin resistance was determined by the Homeosta-
sis Model Assessment Insulin Resistance (HOMA-IR): 
[Fasting insulin (µU/mL) x fasting  blood  gluco-
se  (mmol/L)/22.5]19. Insulin sensitivity was determi-
ned by the Quantitative Insulin Sensitivity Check In-
dex (QUICKI): [1/ (log fasting insulin (µU⁄mL) + log 
fasting glucose (mg/dL)]20. Homeostasis Model As-
sessment-Adiponectin (HOMA-AD) was calculated 
from fasting blood glucose, insulin and adiponectin: 
[fasting glucose (mg⁄dl) x fasting insulin (µU/L) ⁄ Adi-
ponectin (µg/mL)]21. The cutoff of HOMA-IR adopted 
for adolescents was 3.1622 and insulin was 15.023.
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Metabolic syndrome diagnosis
Metabolic syndrome diagnoses were made when 
waist circumference was higher than the 90th percentile 
for age and gender and associated with two or more 
criteria of IDF24: HDL-c values ≤50 mg/dL for girls and 
≤40 mg/dL for boys; concentrations of TG higher than 
150 mg/dL; blood glucose levels higher than 100 mg/
dL, and blood pressure ≥130/85 mmHg. Patients were 
distributed into two groups, with metabolic (MetS) and 
without MetS (Non-MetS). The number of metabolic 
alterations was obtained according to these parameters. 
Statistical analysis
Statistical analyses were performed using PASW Sta-
tistics version 20 (SPSS Inc., Chicago, IL, USA) with 
the level of statistical significance set at p <0.05. The 
distributional assumptions were verified by Kolmogo-
rov–Smirnov test. Parametric variables were expressed 
as means±standard deviation, whereas non-parametric 
variables were expressed as medians (minimum–maxi-
mum). Comparisons between MetS group and Non-
MetS, and according to gender, were made using inde-
pendent t tests for parametric variables and the Mann 
Whitney test for non-parametric variables. Pearson 
and Spearman correlations were performed to test the 
direction and strength of the relationship between the 
variables of the study. Logistic regression analysis was 
employed to determine which factors were predictor 
variables of MetS. Chi-square test was used to verify 
the association between prevalence of categorical va-
riables between MetS and Non-MetS groups.
 A receiver operating characteristic (ROC) curve 
was constructed in order to establish waist circumfe-
rence cut-off points for obese boys and girls that could 
be used to predict MetS. Sensitivity was defined as the 
probability of waist circumference to classify correctly 
those subjects presenting MetS (true positives), whe-
reas specificity was defined as the probability of waist 
circumference to classify correctly those subjects pre-
senting non-MetS (true negatives). The area under the 
ROC curve was employed as a global measure of the 
general precision of waist circumference as a predictor 
of MetS, in which an area of 1 would correspond to 
100% sensitivity and 100% specificity and, thus, repre-
sent a perfect test for discriminating individuals. The 
shortest distance in the ROC curve was calculated using 
the function: √(1 − sensitivity2 ) + (1 − specificity2).
Results
Comparison between entire group with MetS and 
Non-MetS
The entire MetS group (boys + girls) presented sig-
nificantly higher values of body mass, BMI, body fat 
(kg), fat-free mass (kg), waist circumference and vis-
ceral fat (Table I). In relation to metabolic variables, 
MetS group presented significantly higher values of 
Table I 
Antropometric and body composition profile of obese adolescents with and without metabolic syndrome
Non-MetS MetS
Entire group 
(n=145)
Male  
(n=46)
Female  
(n=99)
Entire group 
(n=50)
Male  
(n=33)
Female  
(n=17)
Age (years) 16.49 ± 1.45 16.31 ± 1.17 16.58 ± 1.56 16.56 ± 1.63 16.18 ± 1.57 17.28 ± 1.54
Body mass (kg) 97.22 ± 15.45 104.66 ± 14.80 93.76 ±14.56c 109.95 ± 14.40a 112.07 ± 15.68b 105.83 ± 10.78b
Height (m) 1.66 ± 0.09 1.74 ± 0.08 1.63 ± 0.06c 1.70 ± 0.08a 1.73 ± 0.08 1.64 ± 0.06c
BMI (kg/m2) 35.01 ± 4.34 34.50 ± 4.10 35.25 ± 4.45 38.04 ± 4.81a 37.29 ± 4.83b 39.49 ± 4.55b
Body fat (%) 43.45 ± 7.06 38.46 ± 7.11 45.77 ± 5.73c 44.42 ± 6.35 42.44 ± 6.04b 48.25 ± 5.20c
Fat-free mass (%) 56.55 ± 7.07 61.56 ± 7.14 54.23 ± 5.73c 55.58 ± 6.35 57.56 ± 6.04b 51.75 ± 5.20c
Body fat (kg) 42.59 ± 11.28 40.72 ± 11.36 43.46 ± 11.20 49.19 ± 11.18a 48.04 ± 11.81b 51.41 ± 9.78b
Fat-free mass (kg) 54.64 ± 9.30 63.99 ± 8.57 50.30 ± 5.76c 60.76 ± 8.18a 64.04 ± 7.79 54.39 ± 4.31b,c
Waist circumference (cm) 97.73 ± 9.74 100.97 ± 8.12 96.23 ± 10.09c 108.74 ± 10.02a 109.38 ± 9.99b 107.51 ± 10.27b
Visceral fat (cm) 4.37 ± 1.32 4.95 ± 1.32 4.10 ± 1.24c 5.16 ± 1.59a 5.49 ± 1.67 4.53 ± 1.25c
Subcutaneous fat (cm) 3.82 ± 0.93 3.47 ± 0.76 3.98 ± 0.96c 3.98 ± 0.74 3.82 ± 0.72b 4.29 ± 0.69c
Visceral/subcutaneous fat 1.21 ± 0.46 1.48 ± 0.46 1.08 ± 0.40c 1.34 ± 0.47 1.47 ± 0.45 1.10 ± 0.42c
a Comparison between MetS x Non-MetS groups, p<0.05.
b Comparison between  MetS x Non-MetS by gender, p<0.05.
c Comparison between Female x Male in the same group, p<0.05. 
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glucose, insulin, HOMA-IR, total-cholesterol, LDL-c, 
VLDL-c, TG, ALT, AST, GGT, SBP, DBP, MBP, TC/
HDL-c, LDL-c/HDL-c, TG/HDL-c ratios and HO-
MA-AD (Table II). Significant lower values of QUIC-
KI, HDL-c and adiponectin were also noted in MetS 
group (Table II). 
Comparison between boys with MetS x Non-MetS
The MetS group presented significantly higher va-
lues of body mass, BMI, body fat (% and kg), waist 
circumference and subcutaneous fat (Table I). In rela-
tion to metabolic variables, MetS group presented sig-
nificantly higher insulin, HOMA-IR, total-cholesterol, 
LDL-c, VLDL-c, TG, ALT, AST, SBP, DBP, MBP, 
TC/HDL-c, LDL-c/HDL-c, TG/HDL-c ratios and HO-
MA-AD (Table II). Significant lower values of fat-free 
mass (%), HDL-c and QUICKI were observed in MetS 
compared to Non-MetS (Table I and II).
Comparison between girls with MetS x Non-MetS
The MetS group presented significantly higher va-
lues of body mass, BMI, body fat (kg), fat-free mass 
(kg) and waist circumference (Table I). In relation to 
metabolic variables, MetS group presented significant-
ly higher insulin, HOMA-IR, VLDL-c, TG, SBP, DBP, 
MBP, TC/HDL-c and TG/HDL-c ratios. Significant 
lower values of QUICKI and HDL-c were observed in 
MetS compared to Non-MetS girls. MetS group also 
presented significantly higher leptin/adiponectin ratio 
and HOMA-AD, and lower adiponectin than Non-
MetS group (Table II).
Comparison between gender at same group
Comparing boys and girls with MetS, boys presen-
ted significantly higher values of height, fat-free mass 
(% and kg), visceral fat and visceral/ subcutaneous fat 
compared to girls. On the other hand, girls presented 
significantly higher values of body fat (%) and subcuta-
neous fat (Table I). In relation to metabolic parameters, 
significant higher values of LDL-c, AST, ALT, GGT, 
TC/HDL-c, LDL-c/HDL-c and TG/HDL-c ratios were 
observed in boys with MetS. HDL-c was significantly 
higher in girls compared to boys (Table II).
Analyzing Non-MetS boys and girls, we observed 
that boys presented significantly higher body mass, 
height, fat-free mass (% and kg), waist circumference, 
visceral fat and visceral/subcutaneous fat. Significant 
higher values of body fat (%) and subcutaneous fat 
were observed in girls (Table I). Glucose, AST, ALT, 
GGT, DBP, MBP and TG/HDL-c ratio were signifi-
cantly higher, and HDL-c was significantly lower in 
boys compared to girls. Leptin was also significantly 
higher in girls (Table II).
Prevalence of metabolic syndrome parameters, 
hyperleptinemia and NALFD
Figure 1 illustrates the prevalence of altered para-
meters of MetS, hyperinsulinemia, hyperleptinemia 
and NALFD in the entire group (a), in boys (b) and 
girls (c) with and without MetS. In the entire group, 
significantly higher prevalence of altered waist cir-
cumference, glucose, HLD-c, TG, SBP, DBP, hyper-
insulinemia, insulin resistance and NAFLD were ob-
served in MetS compared to Non-MetS individuals. 
Similar results were noted in the analysis according 
to gender, in boys and girls (Figure 1b and c). Only 
in boys, there was no significant difference in the 
prevalence of high blood glucose between MetS and 
Non-MetS patients.
Correlations of waist circumference
Waist circumference was positively correlated with 
body mass (r=0.77, p=0.00), BMI (r=0.71, p=0.00), 
body fat (%) (r=0.36, p=0.00), body fat (kg) (r=0.69, 
p=0.00), visceral fat (r=0.49, p=0.00), subcutaneous fat 
(r=0.34, p=0.00), insulin (r=0.43, p<0.05), HOMA-IR 
(r=0.44, p<0.05), ALT (r=0.31, p<0.05), AST (r=0.23, 
p<0.05), GGT (r=0.27, p<0.05), SBP (r=0.34, p<0.05), 
DBP (r=0.40, p<0.05), MBP (r=0.40, p<0.05), leptin/
adiponectin ratio (r=0.28, p<0.05) and HOMA-AD 
(r=0.40, p<0.05). Negative correlations between waist 
circumference and QUICKI (r=-0.46, p<0.00), adipo-
nectin (r=-0.24, p<0.05) and adiponectin/leptin ratio 
(r=-0.27, p<0.05) were also observed. Interestingly, 
waist circumference was positively correlated with the 
number of MetS parameters (r=0.57, p=0.00). 
Logistic Regression Analysis
In the logistic regression analysis, using the diag-
nosis of MetS as a dependent variable, it was found 
that body mass, BMI, body fat (%), visceral fat, waist 
circumference, insulin, HOMA-IR, total cholesterol, 
HLD-c, LDL-c, VLDL-c, triglycerides, SBP, DBP 
and adiponectin concentration were predictors to 
development of MetS (Table III). In the analysis ad-
justed by age and gender, waist circumference and 
age were together associated with MetS diagnosis 
(Table III).
Cut-Off point of waist circumference for metabolic 
syndrome
Analysis of the ROC curves revealed cut-off points 
of 111.5 cm for boys and 104.6 cm for girls (Figure 2). 
The area under the ROC curve for the girls group was 
0.792 (p = 0.001) and that for boys group was 0.733 
(p = 0.000).
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Table II 
Biochemical, blood pressure and inflammatory profile of obese adolescents with and without metabolic syndrome
Non-MetS MetS
Entire group 
(n=145)
Male  
(n=46)
Female  
(n=99)
Entire group 
(n=50)
Male  
(n=33)
Female  
(n=17)
Glucose (mg/dl) 90.50 ± 6.64 92.33 ± 7.36 89.65 ± 6.13c 92.88 ± 7.21a 93.67 ± 6.75 91.35 ± 8.02
Insulin (Uu/ml ) 13.86  (3.98 - 32.44)
14.60  
(7.44 - 32.44)
13.30  
(3.98 - 30.30)
18.43  
(7.10 - 60.30)a
18.56  
(8.30 - 60.30)b
18.30  
(7.10 - 35.80)b
HOMA-IR 3.02  (0.85 - 7.52)
3.38  
(1.58 - 7.52)
2.85  
(0.85 - 7.10)
4.29  
(1.45 - 16.07)a
4.26  
(1.86 - 16.07)b
4.36  
(1.45 - 7.77)b
QUICKI 0.325 ± 0.020 0.324 ± 0.017 0.326 ± 0.021 0.309 ± 0.020a 0.308 ± 0.021b 0.310 ± 0.017b
Total cholesterol 
(mg/dl) 161.51 ± 30.99 157.47 ± 35.89 163.39 ± 28.43 179.76 ± 29.93a 184.48 ± 32.42b 170.59 ± 22.51
HDL-c (mg/dl) 47.44 ± 9.49 43.84 ± 8.46 49.11 ± 9.51c 40.62 ± 8.37a 38.76 ± 7.95b 44.24 ± 8.19b, c
LDL-c (mg/dl) 96.41 ± 27.63 94.80 ± 31.94 97.16 ± 25.53 109.65 ± 26.07a 115.25 ± 28.19b 99.12 ± 17.84c
VLDL-c (mg/dl) 16 (7 - 187) 17.5 (7 - 187) 16 (7 - 45) 30 (11 - 54)a 30 (15 - 54)b 31 (11 - 46)b
Triglycerides (mg/dl) 82 (35 - 226) 85 (35 - 202) 80 (35 - 226) 151.5 (55 - 529)a 151 (74 - 529)b 154 (55 - 229)b
AST (U/l) 22 (10 - 60) 24 (15 - 60) 20 (10 - 52)c 25 (15 - 73)a 26.5 (19 - 73)b 20 (15 - 29)c
ALT (U/l) 21 (3 - 146) 27 (3 - 146) 20 (9 - 61)c 27 (12 - 112)a 35.5 (17 - 112)b 22 (12 - 39)c
GGT (U/l) 20 (7 - 155) 26.5 (10 - 155) 18 (7 - 56)c 25 (9 - 89)a 30 (15 - 89) 19 (9 - 41)c
SBP (mmHg) 120  (100 - 190)
120  
(100 - 150)
120  
(100 - 190)
130  
(105 - 150)a
130  
(105 - 150)b
130  
(110 - 150)b
DBP (mmHg) 80  (65 - 110)
80  
(65 - 90)
75  
(65 - 110)c
80 
(70 - 100)a
80  
(70 - 100)b
80  
(70 - 100)b
MBP (mmHg) 90  (76.67 - 136.67)
93.33  
(76.67 - 110)
90  
(80 - 136.67)c
96.67  
(83.33 - 113.33)a
96.67  
(85 - 113.33)b
96.67  
(83.33 - 113.33)b
TC/HDL-c ratio 3.41  (1.72 - 6.97)
3.48  
(2.00 - 6.43)
3.32  
(1.72 - 6.97)
4.55  
(2.69 - 6.67)a
5.17  
(2.69 - 6.67)b
3.55  
(2.96 - 5.62)b,c
LDL-c/HDL-c ratio 2.02  (0.60 - 4.43)
2.07  
(0.72 - 4.43)
1.98  
(0.60 - 4.41)
2.75  
(1.42 - 4.80)a
3.07  
(1.42 - 4.80)b
2.13  
(1.44 - 3.28)c
TG/HDL-c ratio 1.70  (0.58 - 7.79)
2.14  
(0.65 - 5.05)
1.66  
(0.58 - 7.79)c
3.70  
(1.17 - 12.60)a
4.40  
(1.34 - 12.60)b
2.37  
(1.17 - 6.06)b, c
Adiponectin (ug/l) 9.93  (0.26 - 97.17)
8.51  
(2.01 - 42.71)
10.14  
(0.26 - 97.17)
7.38  
(1.83 - 33.46)a
7.80  
(1.87 - 33.46)
5.33  
(1.83 - 12.93)b
Leptin (ng/ml) 30.50  (1.69 100.00)
21.52  
(1.69 – 80.36)
34.51  
(2.73 - 100)c
25.33  
(1.24 - 97.44)
21.36  
(1.24 - 97.44)
40.08  
(4.07 - 96.67)
Leptin/Adiponectin 
ratio
2.00  
(0.19 - 38.93)
1.95  
(0.22 - 22.17)
2.16  
(0.19 - 38.93)
3.27  
(0.15 - 31.11)
2.37  
(0.15 - 31.11)
4.27  
(0.77 - 25.88)b
Adiponectin/ Leptin 
ratio
0.50  
(0.00 - 5.32)
0.51  
(0.05 - 4.58)
0.47  
(0.00 - 5.32)
0.33  
(0.03 - 6.53)
0.42  
(0.03 - 6.53)
0.26  
(0.04 - 1.30)
HOMA-AD 7.34  (0.27 - 361.55)
7.82  
(0.94 - 58.20)
6.75  
(0.27 - 361.55)
13.90  
(2.90 - 183.76)a
12.87  
(2.90 - 183.76)b
14.99  
(3.30 - 51.13)b
a Comparison between MetS x Non-MetS groups, p<0.05; 
b Comparison between  MetS x Non-MetS by gender, p<0.05; 
c Comparison between Female x Male in the same group, p<0.05
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Discussion
The findings of the present study demonstrated sig-
nificantly higher prevalence of altered waist circumfe-
rence, blood glucose, HDL-c, triglycerides and blood 
pressure in MetS than Non-MetS obese adolescents. 
Obese adolescents with MetS also presented signifi-
cantly higher body mass, BMI, body fat, waist circum-
ference, visceral fat, glucose, insulin, HOMA-IR, TC, 
LDL-c, VLDL-c, TG, blood pressure, Castell indices 
(TC/HDL-c, LDL-c/HDL-c and TG/HDL-c) and HO-
MA-AD, as well as, significantly lower QUICKI (Ta-
ble I and II). These results elucidate the higher cardio 
metabolic alterations observed in MetS patients, which 
potentiate cardiovascular risks and atherosclerosis 
process. Therefore, low cost diagnosis is preventive 
and easy to apply in the development countries.
In the current preventive cardiology guidelines, it 
is strongly recommended the identification of MetS in 
clinical practice, once metabolic dysfunction adverse-
ly increases cardiovascular disease24-25. In a long-term 
epidemiologic study, subjects with MetS showed sig-
nificantly higher alterations in ventricle, end-diastolic 
posterior wall thickness, septal wall thickness, relative 
wall thickness, and ventricle end-diastolic diameter 
than subjects without MetS26.
In adolescents, the carotid intima media thickness, 
considered a subclinical marker of atherosclerosis, was 
positively correlated with MetS parameters, such as 
HOMA-IR, LDL-c, VLDL-c, low HDL-c, triglyceri-
Fig. 1.—Prevalence of meta-
bolic syndrome alterations, 
hyperisulinemia, insulin 
resistance, hyperleptinema, 
and non-alcoholic fatty liver 
disease in all obese adoles-
cents (a), boys (b) and girls 
(c) with and without metabo-
lic syndrome.
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des, abdominal subcutaneous fat volume and visceral 
fat volume27. A cross-sectional study of 447 children 
also demonstrated that higher values of blood pressure 
and lower values of HDL-c were associated with carotid 
intima media thickness28. Together, these results rein-
force the role of MetS components with increased risks 
of atherosclerosis progression in early stages of life.
Therefore, the identification of anthropometric pre-
dictors of MetS is crucial in clinical practice, since it 
can be used as an easy and fast method to suggest and 
investigate metabolic complication, in order to impro-
ve its prognostic and treatment. In the present study, 
cut off point of waist circumference for MetS diagno-
sis was found in a sample of 195 obese adolescents 
(111.5 cm for boys and 104.6 cm for girls), based on 
the MetS diagnosis proposed by IDF criteria for chil-
dren and adolescents24.
In multiple regression analysis adjusted for age and 
gender, MetS was predicted by waist circumference in 
a gender-dependent manner. Our analysis indicated that 
the risks of individuals presenting MetS were raised 
by 11% for each additional increase of 1 cm in waist 
circumference (Table III). Moreover, waist circumfe-
rence was positively correlated with body fat, insulin 
resistance, insulin, liver enzymes, blood pressure and 
pro-inflammatory leptin/adiponectin ratio. On the other 
hand, waist circumference was negatively correlated 
with insulin sensibility (QUICKI), adiponectin and an-
ti-inflammatory adiponectin/leptin ratio. In agreement, 
it was demonstrated that waist circumference also co-
rrelated with glycemia, HDL-c and blood pressure in a 
sample of adults6. Confirming the importance of waist 
circumference as an indicator of cardiometabolic risks, 
we also demonstrated that waist circumference was co-
rrelated with the number of MetS parameters.
Visceral fat is closely associated with cardiovascu-
lar risk factors. In obese adolescents, visceral fat was 
the most significant predictor of elevated carotid inti-
Fig. 2.—ROC curve for cut off point of waist circumference for 
metabolic syndrome diagnoses in boys (a) and girls (b).
Table III.  
Logistic regression for the determinants of metabolic 
syndrome.
Metabolic syndrome
OR p -95,00% +95,00%
Age 1.1 0.49 0.84 1.43
Gender 0.32 0.01 0.15 0.70
Waist  
circumference 1.11 0.00 1.06 1.16
Body mass 1.05 0.00 1.03 1.08
BMI 1.15 0.00 1.07 1.23
Body fat (%) 1.05 0.01 1.02 1.08
Visceral fat (cm) 1.46 0.00 1.16 1.85
Waist  
circumference 1.12 0.00 1.08 1.16
Insulin 1.12 0.00 1.06 1.18
HOMA-IR 1.67 0.00 1.32 2.11
Total-cholesterol 1.02 0.00 1.01 1.03
HDL-c 0.91 0.00 0.88 0.95
LDL-c 1.02 0.01 1.01 1.03
VLDL-c 1,10 0,01 1,03 1,18
Triglycerides 1.03 0.00 1.02 1.04
SBP 1.07 0.00 1.04 1.10
DBP 1.12 0.00 1.06 1.19
Adiponectin 0.92 0.01 0.89 0.98
Leptin 0.99 0.48 0.98 1.01
Leptin/Adipo-
nectin ratio 1.02 0.28 0.98 1.07
Adiponectin/
Leptin ratio 0.83 0.41 0.53 1.30
HOMA-AD 1.01 0.15 0.99 1.02
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ma media thickness, being considered a key predictor 
of arterial wall thickening. In this way, visceral fat is 
suggested to be the focus of cardiovascular disease 
prevention in obese adolescents27. The waist circum-
ference is considered an anthropometric method corre-
lated with visceral adiposity in obese adolescents, as 
we observed in the present study. Although, there are 
other main methods for examining abdominal fat, such 
as computed tomography and magnetic resonance, 
they present high costs and radiation exposure, which 
limit their application to be used on a large scale in 
population29. 
Adipose tissue has been considered a secretory or-
gan and a potent source of hormones, peptides and 
adipokines involved in food intake regulation, glucose 
and lipid metabolism, inflammation, coagulation and 
blood pressure control. Furthermore, abdominal obe-
sity has been identified as a particularly harmful fat 
depot, associated with chronic inflammatory response 
characterized by abnormal adipokines production and 
the activation of several pro-inflammatory signaling 
pathways. This low-grade inflammation is characteri-
zed by high levels of TNF-α, IL-6, leptin, c reactive 
protein, resistin, PAI-1 and low levels of adiponectin. 
In this way, abdominal obesity is related to the main 
risk factor to development of pathogenesis of MetS, 
insulin resistance, NAFLD, cardio metabolic risks and 
all-cause of mortality3,5. 
One of our objectives was to investigate the preva-
lence of altered metabolic parameters, such as NA-
FLD in obese adolescents with and without MetS. 
MetS obese adolescents presented significantly higher 
prevalence of NAFLD (69.7% in boys and 58.82% in 
girls) compared to Non-MetS (32.61% in boys and 
22.68% in girls) (Figure 1). The NAFLD can be consi-
dered as a hepatic manifestation of MetS. This disease 
comprises a spectrum ranging from simple steatosis 
to steatohepatitis, which includes varying degrees of 
inflammation and fibrosis, progressing to end-stage 
liver disease with cirrhosis. Recently, it was demons-
trated that visceral fat predicts NAFLD, and the risk 
individuals presenting NAFLD were raised by 60.6% 
for each additional increase of 1 cm in visceral fat in 
obese adolescents12. 
Deposition of lipid within the liver represents part 
of an abnormal lipid partitioning pattern, most com-
monly associated with high amount of intra-abdominal 
fat. Lipid deposition in the liver can be a cause of insu-
lin resistance, via local acceleration of lipogenesis, and 
hepatic insulin resistance, leading to further compen-
satory hyperinsulinemia and hyperglycemia30. 
We also observed significantly higher values of AST, 
ALT and GGT in MetS adolescents. Similarly, Fernán-
dez-Ruiz et al. (2014)31 demonstrated that MetS patients 
presented significant higher values of ALT compared to 
Non-MetS patients. Corroborating, the literature indi-
cates that elevations in liver enzymes are considered 
the early surrogate markers of liver dysfunction, such 
as NAFLD. Moreover, the elevation in liver enzymes 
is associated with MetS and related to type 2 diabetes, 
being considered one potential biochemical parameter 
in clinical practice. Significant increased risk of 1.2-
fold of developing type 2 diabetes per 1-SD increment 
ALT and GGT levels was observed in young adults 
after a follow up of 16-years32. In children and adoles-
cents, Patel et al. (2011)33 demonstrated that ALT was 
associated with BMI and some MetS parameters, such 
as TC, HDL-c and HOMA-IR. The authors concluded 
that ALT is an established biomarker of ectopic fat ac-
cumulation in the liver, and may help improve the risk 
assessment of MetS and related disorders in the pedia-
tric population, especially adolescents.
A noteworthy fact is the higher prevalence of insu-
lin resistance in MetS obese adolescents compared to 
Non-MetS group. We observed a significantly higher 
prevalence of 80% in MetS obese adolescents (78.79% 
in boys and 82.35% in girls) compared to 46.90% in 
Non-MetS (54.35 in boys and 43.43 in girls) (Figure 
1). Insulin resistance presents a key role in the develop-
ment of metabolic obesity comorbidities in childhood, 
being necessary to be considered in clinical practice, 
since it is suggested as one of the pathophysiological 
basis of metabolic syndrome4. Moreover, insulin re-
sistance was considered an independent predictor of 
carotid intima media thickness, suggesting its role on 
atherosclerosis development in obese adolescents34. 
Additionally, MetS obese adolescents presented 
significantly lower values of adiponectin. Similar re-
sult was observed by Calcaterra et al. (2009)35 who 
demonstrated that obese children and adolescents also 
presented significantly lower values of adiponectin, 
reaching a 10 times greater reduction. This adipokine 
is secreted in low proportion in obesity condition, and 
it can present an insulin-sensitizing and an anti-athero-
genic role9. Adiponectin is believed to reduce atheros-
clerosis progression by slowing endothelial activation, 
monocyte and macrophage adhesion and activation, 
platelet aggregation, and smooth muscle cell prolife-
ration. Adiponectin is also involved in atherosclero-
sis prevention by increasing nitric oxide, preventing 
endothelial dysfunction, and by local inhibition of 
inflammatory molecules. Thus, hypoadiponectinemia 
directly promotes pathological reactions in cardiovas-
cular system, and can lead to insulin resistance, type 2 
diabetes and atherosclerosis formation36.
In a 16-year longitudinal study conducted with 
2196 individuals, low adiponectin levels conferred a 
higher risk of cardiovascular disease37. Corroborating, 
subjects in the highest tertile of adiponectin had lower 
risks of having MetS, being adiponectin negatively as-
sociated with increased MetS components38. 
On the other hand, in a previous study, leptin predic-
ted MetS in men and women. It was observed that the 
risk of MetS increased with higher levels of leptin after 
adjusting for potential confounders in women. Leptin 
remained independently associated with MetS risk af-
ter additional adjustment for adiposity, cytokines and C 
Reactive Protein39. One important data obtained of the 
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HELENA study conducted in a sample of 927 European 
adolescents showed that leptin presented significantly 
progressive and linear increase according to BMI, being 
positively correlated with BMI during adolescence40. 
Moreover, we are able to show that leptin/adiponec-
tin ratio was significantly higher in girls with MetS 
compared to Non-MetS (Table II). This ratio has been 
suggested to be a marker of cardiovascular risks, sin-
ce it was significantly correlated to MetS parameters, 
such as, systolic blood pressure, HDL-c and insulin 
resistance. Moreover, L/A ratio was considered an in-
dependent predictor of carotid intima media thickness 
in adults41. Together, these results highlight the impor-
tance of controlling metabolic parameters and adipoki-
nes in order to prevent and delay future cardiovascular 
risks associated with obesity. 
Park et al. (2013)42 demonstrated that higher L/A ra-
tios were signifi cantly associated with increased mor-
tality in nondiabetic peritoneal dialysis patients. The 
impact of the L/A ratio on patient sur vival remained 
significant even after adjustments for BMI and other 
confounding variables. Non-survival patients presen-
ted significantly higher values of L/A ratio, which was 
associated with increased mortality. Although, signifi-
cant reduction in L/A ratio can be observed with 7% of 
weight loss in obese adolescents9.
Our study presents some limitation, such as the sam-
ple size of volunteers analyzed. The waist circumfe-
rence cut-off points proposed in this study need to be 
explored in a large population of obese adolescents, 
since the analyzed population is entirely Brazilian. 
Additional investigation including a control group and 
long-term follow-up are also needed. 
In conclusion, we found that waist circumference is 
correlated with MetS parameters, inflammatory bio-
markers and visceral fat. High prevalence of NAFLD 
and altered parameters were observed in obese ado-
lescents diagnosed with MetS. Therefore, the results 
suggest that waist circumference procedure may be a 
simple and fast method of assessing visceral adiposity, 
being an indicator of MetS and metabolic alterations to 
be considered in clinical practice. Finally, we demons-
trated the important role of pro/anti-inflammatory adi-
pokines mediating the MetS diagnosis, especially in 
girls, once we showed high L/A ratio in MetS group 
and low adiponectin in all analyzed patients.
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